Can continuous glucose monitoring provide objective documentation of hypoglycemia unawareness?

Endocrine Practice

Volumn 11, Issue 2, 2005, Pages 83-90

  Streja, Dan ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; AWARENESS; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETES CONTROL; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE DURATION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTIVARIATE ANALYSIS; PREDICTION; QUESTIONNAIRE; SELF MONITORING; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 18744383343     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.11.2.83     Document Type: Article

References (57)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
2. Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes. 1997;46:271-286.
3. Bolli GB. Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes mellitus. Rev Endocr Metab Disord. 2003;4:335-341.
4. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM: a prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18:517-522.
5. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 2001;24:2030-2034.
6. Sachedina N, Pickup JC. Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in type 1 diabetic subjects. Diabet Med. 2003;20:1012-1015.
7. McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes [erratum in Diabetes Care. 2003;26:553]. Diabetes Care. 2002;25:1499-1503.
8. Guerci B, Floriot M, Bohme P, et al. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care. 2003;26:582-589.
9. Metzger M, Leibowitz G, Wainstein J, Glaser B, Raz I. Reproducibility of glucose measurements using the glucose sensor. Diabetes Care. 2002;25:1185-1191.
10. Steil GM, Rebrin K, Mastrototaro J, Bernaba B, Saad MF. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther. 2003;5:27-31.
11. Gross T, Mastrototaro J, Shin J, Phongpharnich P, Shi M. Improved performance of the Medtronic-MiniMed CGMS using redesigned glucose sensors and updated calibration software [abstract]. Diabetes. 2003;53:A95.
12. Marcovina SM, Landin-Olsson M, Essen-Moller A, Palmer JP, Lernmark A. Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies. Int J Clin Lab Res. 2000; 30: 21-26.
13. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke W. Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care. 1997;20:1655-1658.
14. Kovatchev BP, Cox DJ, Gonder-Frederick L, Clarke WL. Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes. Diabetes Technol Ther. 2002;4:295-303.
15. Janssen MM, Snoek FJ, Heine RJ. Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia. Diabetes Care. 2000;23:529-532.
16. The SAS Institute, Inc. SAS/Stat User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute, 1995.
17. Leese GP, Wang J, Broomhall J, et al (DARTS/MEMO Collaboration). Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26:1176-1180.
18. Muhlhauser I, Overmann H, Bender R, Bott U, Berger M. Risk factors of severe hypoglycaemia in adult patients with type 1 diabetes - a prospective population based study. Diabetologia. 1998;41:1274-1282.
19. Palmer JP, Fleming GA, Greenbaum CJ, et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001 [erratum in Diabetes. 2004;53:1934]. Diabetes. 2004;53:250-264.
20. Barkai L, Vamosi I, Lukacs K. Prospective assessment of severe hypoglycaemia in diabetic children and adolescents with impaired and normal awareness of hypoglycaemia. Diabetologia. 1998;41:898-903.
21. Kovatchev BP, Cox DJ, Farhy LS, Straume M, Gonder-Frederick L, Clarke WL. Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose. J Clin Endocrinol Metab. 2000;85:4287-4292.
22. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care. 1998; 21:1870-1875.
23. Cryer PE. Hypoglycemia risk reduction in type 1 diabetes. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S412-S423.
24. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes. 1997;46:1328-1335.
25. Davis SN, Mann S, Galassetti P, et al. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes. 2000;49:1897-1903.
26. Murata GH, Duckworth WC, Shah JH, Wendel CS, Hoffman RM. Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Res Clin Pract. 2004;65:61-67.
27. Murata GH, Hoffman RM, Shah JH, Wendel CS, Duckworth WC. A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: the Diabetes Outcomes in Veterans Study (DOVES). Arch Intern Med. 2004;164:1445-1450.
28. Gold AE, Frier BM, MacLeod KM, Deary IJ. A structural equation model for predictors of severe hypoglycaemia in patients with insulin-dependent diabetes mellitus. Diabet Med. 1997;14:309-315.
29. Bragd J, Adamson U, Lins PE, Wredling R, Oskarsson P. A repeated cross-sectional survey of severe hypoglycaemia in 178 type 1 diabetes mellitus patients performed in 1984 and 1998. Diabet Med. 2003;20:216-219.
30. Kovatchev BP, Cox DJ, Kumar A, Gonder-Frederick L, Clarke WL. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther. 2003;5:817-828.
31. Cox DJ, Gonder-Frederick LA, Kovatchev BP, et al. Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia. Diabetes Care. 1999;22:2018-2025.
32. Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabet Med. 2003;20:238-241.
33. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care. 2004;27:734-738.
34. Bode B, Gross K, Rikalo N, et al. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther. 2004;6:105-113.
35. Mauras N, Beck RW, Ruedy KJ, et al. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) Accuracy Study. J Pediatr. 2004;144:770-775.
36. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001;24:1858-1862.
37. Conrad SC, Mastrototaro JJ, Gitelman SE. The use of a continuous glucose monitoring system in hypoglycemic disorders. J Pediatr Endocrinol Metab. 2004;17:281-288.
38. Diabetes Research in Children Network (DIRECNET) Study Group. The accuracy of the CGMS in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) Accuracy Study. Diabetes Technol Ther. 2003;5:781-789.
39. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 2003;52:2790-2794.
40. Cheyne EH, Cavan DA, Kerr D. Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers. Diabetes Technol Ther. 2002;4:607-613.
41. Evans ML, Pernet A, Lomas J, Jones J, Amiel SA. Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care. 2000;23:893-897.
42. Kubiak T, Hermanns N, Schreckling HJ, Kulzer B, Haak T. Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabet Med. 2004;21:487-490.
43. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet. 1994;344:283-287.
44. Dagogo-Jack S, Fanelli CG, Cryer PE. Durable reversal of hypoglycemia unawareness in type 1 diabetes [letter]. Diabetes Care. 1999;22:866-867.
45. Cox DJ, Gonder-Frederick L, Julian DM, Clarke W. Long-term follow-up evaluation of blood glucose awareness training. Diabetes Care. 1994;17:1-5.
46. Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke W. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care. 2001;24:637-642.
47. Kinsley BT, Weinger K, Bajaj M, et al. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care. 1999;22:1022-1028.
48. Fritsche A, Stefan N, Haring H, Gerich J, Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med. 2001;134(9 Pt 1):729-736.
49. Jorgensen HV, Pedersen-Bjergaard U, Rasmussen AK, Borch-Johnsen K. The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care. 2003;26: 1106-1109.
50. Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycaemia - a prospective population-based study. Exp Clin Endocrinol Diabetes. 2003;111: 364-369.
51. ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care. 2000;23:1467-1471.
52. Morris AD, Boyle DI, McMahon AD, et al. ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes: DARTS/MEMO Collaboration (Diabetes Audit and Research in Tayside, Scotland/Medicines Monitoring Unit). Diabetes Care. 1997;20:1363-1367.
53. Thamer M, Ray NF, Taylor T. Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas. Clin Ther. 1999;21:1387-1400.
54. Deininger E, Oltmanns KM, Wellhoener P, et al. Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans. Clin Pharmacol Ther. 2001;70:362-369.
55. Oltmanns KM, Deininger E, Wellhoener P, et al. Influence of captopril on symptomatic and hormonal responses to hypoglycaemia in humans. Br J Clin Pharmacol. 2003;55:347-353.
56. Chaturvedi N, Fuller JH. ACE inhibitors and risk of hypoglycemia in people with diabetes [letter]. Diabetes Care. 1998;21:470-472.
57. Strachan MW, Frier BM. Risk of severe hypoglycemia in diabetes patients taking ACE inhibitors [letter]. Diabetes Care. 1998;21:470.